KR100373498B1 - Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis - Google Patents

Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis Download PDF

Info

Publication number
KR100373498B1
KR100373498B1 KR1020010066584A KR20010066584A KR100373498B1 KR 100373498 B1 KR100373498 B1 KR 100373498B1 KR 1020010066584 A KR1020010066584 A KR 1020010066584A KR 20010066584 A KR20010066584 A KR 20010066584A KR 100373498 B1 KR100373498 B1 KR 100373498B1
Authority
KR
South Korea
Prior art keywords
extract
pleurotus eryngii
prevention
osteoporosis
treatment
Prior art date
Application number
KR1020010066584A
Other languages
Korean (ko)
Inventor
Jeong Hwa Baek
Hyeon Man Kim
Hyung Gun Kim
Jong Yeo Kim
Jung Keun Kim
Se Won Kim
Seon Yle Ko
Byung Eui Lee
Kwi Ok Oh
Hyun Mo Ryoo
Kyung Mi Woo
Original Assignee
Jung Keun Kim
Se Won Kim
Kwi Ok Oh
Oscotec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jung Keun Kim, Se Won Kim, Kwi Ok Oh, Oscotec Inc filed Critical Jung Keun Kim
Priority to KR1020010066584A priority Critical patent/KR100373498B1/en
Application granted granted Critical
Publication of KR100373498B1 publication Critical patent/KR100373498B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/208—Fungi extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: An extract of Pleurotus eryngii and a pharmaceutical composition containing the same extract for facilitating the bone formation and for prevention and treatment of bone diseases such as osteoporosis are provided. CONSTITUTION: An extract of Pleurotus eryngii capable of facilitating the proliferation of osteoblast and inhibiting the proliferation of osteoclast is prepared by using a solvent selected from water and alcohol, wherein the water extract of Pleurotus eryngii is prepared by heating a mixture of Pleurotus eryngii and water; the alcohol extract of Pleurotus eryngii is prepared by using 5 to 100% ethyl alcohol or 5 to 100% methyl alcohol. A pharmaceutical composition for facilitating the bone formation and for prevention and treatment of bone diseases such as osteoporosis contains the extract of Pleurotus eryngii as an active ingredient.
KR1020010066584A 2001-10-27 2001-10-27 Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis KR100373498B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010066584A KR100373498B1 (en) 2001-10-27 2001-10-27 Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010066584A KR100373498B1 (en) 2001-10-27 2001-10-27 Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis

Publications (1)

Publication Number Publication Date
KR100373498B1 true KR100373498B1 (en) 2003-02-25

Family

ID=37416719

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010066584A KR100373498B1 (en) 2001-10-27 2001-10-27 Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis

Country Status (1)

Country Link
KR (1) KR100373498B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040046313A (en) * 2002-11-27 2004-06-05 파진바이오 주식회사 Health-supporting food being effective a hypertension
KR100555904B1 (en) 2004-05-19 2006-03-03 주식회사 오스코텍 A herbal mixture extract of Pleurotus eryngii and Acanthopanacis Cortex and composition comprising the same for prevention and treatment of osteoporosis
WO2006088324A1 (en) * 2005-02-18 2006-08-24 Oscotec Inc. A herbal mixture extract of pleurotus eryngii, acanthopanacis cortex and notoginseng radix and a composition comprising the same for prevention and treatment of periodontitis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040046313A (en) * 2002-11-27 2004-06-05 파진바이오 주식회사 Health-supporting food being effective a hypertension
KR100555904B1 (en) 2004-05-19 2006-03-03 주식회사 오스코텍 A herbal mixture extract of Pleurotus eryngii and Acanthopanacis Cortex and composition comprising the same for prevention and treatment of osteoporosis
WO2006088324A1 (en) * 2005-02-18 2006-08-24 Oscotec Inc. A herbal mixture extract of pleurotus eryngii, acanthopanacis cortex and notoginseng radix and a composition comprising the same for prevention and treatment of periodontitis
US7794760B2 (en) 2005-02-18 2010-09-14 Oscotec Inc. Herbal mixture extract of Pleurotus eryngii, Acanthopanacis Cortex and Notoginseng Radix and a composition comprising the same for prevention and treatment of periodontitis

Similar Documents

Publication Publication Date Title
HK1016980A1 (en) Methylsulfonyl)phenyl-2-(5H)-furanones as cox-2 inhibitors
MXPA04004498A (en) N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation.
UA39166C2 (en) derivatives of N-hydroxyurea AS inhibitors of lipoxygenase by mammals, method for the preparation thereof and method for inhibiting lipoxygenase by mammals
AU2002239344A1 (en) Pyrazolopyridines
MXPA02007942A (en) Pyrrolopyrimidinone derivatives, process of preparation and use.
HK1048990A1 (en) Novel compounds.
ATE457027T1 (en) SUBSTITUTED 1,4,8-TRIAZASPIROÄ4.5 DECAN-2-ON COMPOUNDS FOR THE TREATMENT OF OBESITY
PL1730144T3 (en) Substituted 1,4,8-triazaspiro¬4.5 decan-2-one compounds
CY2469B1 (en) Pharmaceutical compositions for sustained release of the hmg-coa reductase inhibitor fluvastatin.
BRPI0410669A (en) caspase inhibitors and their uses
DE60112330D1 (en) Pyrazolopyridinderivate
AU1428801A (en) Novel (1,2,3)-triazolo(4,5-D)pyrimidine compounds
EA200000355A2 (en) INDUSTRIAL PRODUCTS
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2005065639A3 (en) Novel pharmaceutical compositions
WO2001000617A3 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
WO2005055943A3 (en) Vinorelbine derivatives
KR100373497B1 (en) Extract of rehmanniae radix and pharmaceutical composition containing the same for facilitating bone formation of children and for prevention and treatment of bone diseases such as osteoporosis
WO2002026726A3 (en) Antiviral compositions and methods of use
KR100373498B1 (en) Extract of pleurotus eryngii and pharmaceutical composition containing the same for facilitating bone formation and for prevention and treatment of bone diseases such as osteoporosis
DE60139409D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A DIBENOCOCYCLOOCTANLIGNANE DERIVATIVE FOR THE PREVENTION AND TREATMENT OF NEURODEEGENERATIVE DISEASES
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
DE69816047D1 (en) (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
WO2001007418A3 (en) Ceramide analogs, process for their preparation and their use as antitumor agents
RS20050738A (en) Pharmaceutical combination for the treatment of s pasticity and/or pain

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130204

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20140123

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20150129

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20190130

Year of fee payment: 17